Best Analyst Reports for Pfizer, AT&T and Intuit
Friday, August 27, 2021
Zacks Research Daily features the best research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), AT&T Inc. (T) and Intuit Inc. (INTU). These research reports were handpicked from over 70 reports released today by our team of analysts.
You can see all today’s research reports here >>>
Actions of Pfizer outperformed Zacks’ large-cap pharmaceutical industry over the past year (+ 36.6% vs. + 23.3%). The Zacks analyst believes his efforts to drive growth through acquisitions, licensing and collaboration agreements bode well.
The Consumer Healthcare joint venture with Glaxo and the merger of the Upjohn unit with Mylan not only diversifies its portfolio of innovative medicines and vaccines, but is also expected to drive revenue growth. Its COVID-19 vaccine candidate is now approved for emergency use in several countries and has become a key contributor to revenue. However, currency headwinds and price pressure are key headwinds.
(You can read the full research report on Pfizer here >>>)
AT&T stocks have gained + 0.1% in the past six months against Zacks Wireless National’s industry gain of + 3.2%, but things appear to be improving lately for the company. Zacks analyst believes it is well positioned to benefit from solid growth in subscriber numbers thanks to a resilient business model and a strong cash position.
The company aims to split its media assets and merge them with Discovery’s complementary assets to focus on core operations, debt burden reduction and asset monetization. AT&T, however, is experiencing a steady decline in subscribers to linear television as well as traditional services. Its efforts to woo customers with discounts and freebies are having an impact on its margins.
(You can read the full research report on AT&T here >>>)
Actions of Intuit gained + 47.9% during the year-to-date period against Zacks’ computer software industry gain of + 30.8%. The Zacks analyst believes that Intuit has benefited from strong revenue momentum from the online ecosystem as well as strong business tax revenues.
The TurboTax Live offering also stimulated growth in the Consumption Tax business. Its strategy of shifting its business to a cloud-based subscription model is likely to generate stable revenues over the long term. High costs and expenses due to increased investments in marketing and engineering teams are expected to continue to weigh on bottom lines, at least in the near term.
(You can read the full research report on Intuit here >>>)
Other noteworthy reports we present today include Novartis AG (NVS), Automatic Data Processing, Inc. (ADP) and Booking Holdings Inc. (BKNG).
Note: Sheraz Mian heads Zacks’ equity research department and is a renowned expert on aggregate earnings. He is frequently cited in print and electronic media and publishes the weekly Income trends and Income overview reports. If you would like to receive an email notification every time Sheraz publishes a new article, please click here >>>
5 actions in the process of doubling
Each was selected by a Zacks expert as the # 1 favorite stock to earn + 100% or more in 2021. Previous recommendations climbed + 143.0%, + 175.9%, + 498.3% and + 673.0%.
Most of the stock in this report is flying under Wall Street’s radar, which provides a great opportunity to get into the ground floor.
Today, discover these 5 potential circuits >>
Click to get this free report
Novartis AG (NVS): free stock analysis report
AT&T Inc. (T): Free Stock Analysis Report
Automatic Data Processing, Inc. (ADP): Free Stock Analysis Report
Pfizer Inc. (PFE): Free Inventory Analysis Report
Intuit Inc. (INTU): Free Stock Analysis Report
Booking Holdings Inc. (BKNG): Free Stock Analysis Report
To read this article on Zacks.com, click here.
Zacks investment research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.